E V Popova

8PUBLICATIONS
49CO-AUTHORS
AutoimmunityMedical bacteriologyMolecular medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 05, 2023
[Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population].

S A Sivertseva, A M Prilenskaya, E V Popova

|Jan 31, 2023
[Gut microbiota in patients with relapsing-remitting multiple sclerosis].

M V Tardov, Sh Talapbek, N V Sturov

|Aug 01, 2022
[New opportunities in the treatment of patients with multiple sclerosis (Resolution of the Council of Experts on April 23, 2022, Moscow, JSC «BIOCAD»)].

N N Spirin, Ya V Vlasov, M N Zakharova

|Aug 13, 2021
[Ofatumumab - a new drug for the treatment of multiple sclerosis].

A N Boyko, N F Smirnova, I A Shchukin

|Aug 27, 2020
[New tools for early detection of multiple sclerosis progression: MSProDiscuss questionnaire].

A I Volkov, E V Popova

|Apr 24, 2020
[Updated recommendations of the Council of Experts on the use and safety of alemtuzumab (Lemtrada)].

N V Khachanova, K Z Bakhtiyarova, A N Boyko

Pageof 2